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In this study, we investigated the role of the membrane-proximal region of the human parainfluenza virus type 2 (HPIV2)
F protein by mutational analysis, including deletion, insertion, and substitution. Deletion or replacement of the entire 12 amino
acid region (aa 474–485) of the HPIV2 F protein completely abolished its fusion activity when coexpressed with the HPIV2
HN protein. Deletion of groups of four of aa 478–485, single alanine, or other amino acid substitutions among aa 478–485
had minimal or limited effects on HPIV2 F/HN-induced cell fusion. However, a significant reduction in, or complete inhibition
of, fusion activity was observed when aa 474–477 were deleted, or the N475, F476, or F477 residues were singly substituted
with alanine. In addition, insertions of four amino acids at this region or deletion of eight or more amino acids significantly
reduced F protein fusion activity. The oligomerization patterns and levels of cell surface expression of the mutant F proteins
were compared to those of the wild-type HPIV2 F protein. The mutant HPIV2 F proteins defective in fusion were also found
to be unable to initiate hemifusion, indicating that there is a specific requirement for three specific amino acids as well as
the spacing in this region for initiating lipid mixing. © 2001 Academic Press
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fINTRODUCTION
Enveloped viruses enter the cell by membrane fusion,
which involves the fusion of the viral envelope and the
target membrane. Paramyxoviruses effect their entry into
the cell by the combination of functions of two envelope
glycoproteins, the hemagglutinin/neuraminidase (HN)
glycoprotein and the fusion glycoprotein (F). The HN
protein not only provides effective binding to the target
membrane through interaction with sialic acid-contain-
ing receptors but also provides a supporting role for the
F protein to assume the conformation required for fusion
activity. The F protein is thought to be directly involved in
the membrane fusion process (Lamb, 1993). Unlike influ-
enza virus, which fuses with cellular membranes only
after exposure to acid pH, paramyxoviruses fuse at the
plasma membrane at neutral pH. Although some
paramyxovirus F protein can induce cell-to-cell fusion
without their homotypic HN proteins (Alkhatib et al., 1990;
Horvath et al., 1992; Karron et al., 1997), with most
aramyxoviruses coexpression of F and HN from the
ame paramyxovirus serotype in the same cell is re-
uired for successful fusion (Horvath et al., 1992; Hu et
l., 1992; Cattaneo and Rose, 1993; Malvoisin and Wild,
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52993; Bousse et al., 1994; Heminway et al., 1994), sug-
esting that a type-specific interaction between the ho-
otypic F and HN proteins is required to trigger their
usion activity.
The paramyxovirus F protein is a type I integral mem-
rane protein, which has the typical structure including
n ectodomain, transmembrane anchor, and cytoplasmic
ail. The F protein is synthesized as an inactive precursor
Fo), which is then posttranslationally glycosylated and
nzymatically cleaved into two disulfide-linked subunits,
1 and F2, during its intracellular transport. This cleav-
ge is essential for the fusion capacity of the F protein
nd for virus infectivity (Homma and Ohuchi, 1973;
cheid and Choppin, 1974; Nagai et al., 1976). The new
-terminus of F1 generated by the cleavage is a highly
onserved hydrophobic sequence described as the “fu-
ion peptide,” believed to make the initial contact with
he target membrane. Previous analyses of deduced F
rotein sequences indicated that paramyxovirus F pro-
eins contain two heptad repeats. Heptad repeat A (HRA)
s adjacent to the fusion peptide and heptad repeat B
HRB) is adjacent to the transmembrane domain. There
s evidence that these two heptad repeat regions form
mportant structural elements in the F protein during the
usion process (Joshi et al., 1998; Baker et al., 1999;
Dutch et al., 1999; Matthews et al., 2000).
Previous studies with peptide inhibitors showed that
peptides derived from HRB plus the region between the
HRB and the transmembrane domain of the paramyxo-
virus HPIV-3 fusion (F) protein can more effectively inhibit
53PARAINFLUENZA VIRUS F PROTEINvirus-induced cell fusion than can peptides derived only
from the HRB region (Yao and Compans, 1996). The
spacing between HRB and the transmembrane domain
boundary of the simian virus 5 (SV5) fusion protein was
previously shown to be critical for fusion activity (Zhou et
al., 1997). In this study, we used site-directed mutagen-
esis to investigate the requirements for 12 membrane-
proximal residues present in this region of the HPIV2 F
as components involved in the fusogenic activity of the F
protein. The mutant F proteins were analyzed for cell-to-
cell membrane fusion activity and the ability to undergo
the protein maturation process, including oligomeriza-
tion and cell surface expression. In addition, we synthe-
sized peptides with deletions of residues in this region
and compared their ability to inhibit membrane fusion
with peptides that have the same sequence as the F
protein. Based on the results presented here, we postu-
late a possible role of these membrane-proximal amino
acids.
RESULTS
Construction of HPIV2 F mutants
Our definition of the HRB motif of the HPIV2 F protein
is based on the amphipathic b-helical secondary struc-
ture model and on the heptad repeat pattern conserved
in the amino acid sequence of paramyxovirus fusion
glycoproteins. The HRB motif of HPIV2 F contains three
heptadic leucine and isoleucine residues, which form a
leucine zipperlike domain. There are 12 amino acids that
lie between the HPIV2 F protein HRB region and the
putative boundary of the TM domain. To investigate
whether this region of the F protein could be involved in
the fusion process, we constructed a series of F mutants
in this region. A schematic diagram of the HPIV2 F
mutants is presented in Figs. 1A and 1B. As a first step
in determining whether this intervening region is re-
quired for F protein fusion activity, an F mutant protein
with a deletion of the 12 amino acids (from aa 474 to aa
485) was constructed by PCR-based mutagenesis. Next,
a chimeric F protein in which aa 474–485 were replaced
by the corresponding domain aa 483–493 in the heterol-
ogous HPIV3 F protein was constructed. Third, we di-
vided this region into three groups and deleted a group
of four amino acids in each construct. In addition we
constructed mutants with the last eight amino acids
deleted and with four amino acids inserted at both aa
478 and aa 486 positions. Finally, mutants with alanine or
other indicated substitutions in the aa 474–485 region
were constructed.
Cell surface expression and oligomerization of F
mutants
Since levels of cell surface expression of fusion pro-
teins can affect membrane fusion, we compared thelevels of cell surface expression of the wild-type and
mutant F proteins. At 16 h posttransfection, HeLa T4 cells
were fixed in 2% paraformaldehyde for 30 min on ice. The
cell surface F proteins were reacted with polyclonal
rabbit antibodies against PI2 and stained with fluores-
cein isothiocyanide (FITC)-conjugated goat anti-rabbit
immunoglobulin G, after which the cell surface expres-
sion levels of the F protein mutants were quantitated by
FACS analysis (Table 1). We observed that the majority of
the mutant F glycoproteins (S474A, N475A, F477A,
N479A, Q480A, A481R, R482A, A484K, K485A, 474del12,
474-PI3, 474del4, 482del4, 478del8, F476W, F476Y, F476I,
F477W, and F477Y) had similar or higher levels of cell
surface expression than that of the wt PI2 F; other F
mutants (F476A, A478N, T483A, 478del4, 47814, 48614,
N475Q, N475D, F476H, and F477H) had lower levels of
cell surface expression than that of the wt HPIV2 F.
To examine whether the altered HPIV 2F proteins were
able to undergo the normal oligomerization process,
HeLa T4 cells expressing wt and mutant F proteins were
labeled with [35S]Met/Cys using a pulse-chase protocol.
Cell lysates were extracted using the detergent 0.5%
Nonidet P-40 and treated with 3,39-dithiobis (sulfosuccin-
imidyl propionate) (DTSSP). F molecules were then iso-
lated by immunoprecipitation and were analyzed by non-
reducing SDS–PAGE and autoradiography. As shown in
Fig. 2, we observed a ladder of three prominent bands in
both wt F-expressing and mutant F-expressing cell ex-
tracts. The estimated molecular weights are consistent
with the interpretation that the second band represents a
dimer and the third band represents a trimer of the F
protein (Russell et al., 1994). Since all of the mutant F
proteins formed a pattern of oligomers, which was very
similar to those observed for the wt F protein (Yao and
Compans, 1995; Tong and Compans, 1999), these data
suggest that the 12 membrane-proximal amino acids are
not required for F protein oligomerization.
Fusion activity of F mutants
As described previously, the expressed HPIV2 F pro-
tein does not induce cell fusion by itself, but efficiently
induces cell fusion when coexpressed with the HPIV
2HN protein (Hu et al., 1992). To investigate the role of
these 12 membrane-proximal residues (aa 474–485) in F
protein fusion activity, we coexpressed the F protein
mutants with the wt HPIV2 HN protein in HeLaT4 cells
using the recombinant vaccina virus (VV) T7 expression
system. The cells were observed after 16 h for syncytium
formation. The extent of syncytium formation was also
quantitatively determined by a fusion-dependent reporter
gene activation assay. As shown in Fig. 3A, mutant
474del12 with deletion of the region aa 474–485 of the PI2
F protein or mutant 474-PI3 with replacement of this
region of the PI2 F with the corresponding region (aa
483–493) from HPIV3 F (HPIV2-474PI3) completely lacked
54 TONG ET AL.FIG. 1. Schematic diagrams of the wild-type HPIV2 F protein and mutant HPIV2 F proteins shown in (A) and (B). The positions of the fusion peptide
(FP), heptad repeat A (HRA), heptad repeat B (HRB), and transmembrane domain (TM) are indicated by shaded boxes. wtPI2 F represents the wild-type
HPIV2 F protein, in which the 12 proximal transmembrane amino acids are indicated. The designations 474del12, etc. refer to deletion mutants and
the deleted residues are indicated as “-” in each sequence. The designations 47814, etc. refer to insertion mutants. The three-digit number represents
the position of the altered residue and the one- or two-digit number represents the numbers of residues deleted or inserted. The designations S474A,
etc. are substitution mutants. The substituted residues are bolded in each sequence. 474-PI3 is a chimeric mutant, in which the 12 proximal
transmembrane amino acids in HPIV2 F protein are replaced by the 11 proximal transmembrane amino acids in the HPIV3 F protein.
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55PARAINFLUENZA VIRUS F PROTEINfusogenicity, indicating that these 12 membrane-proxi-
mal amino acids are not dispensable and that a specific
amino acid sequence is required for PI2 F protein fusion
activity. Mutant F proteins having deletions of groups of
four of the last eight amino acids (aa 478–485) showed
wild-type levels of fusion activity, but the F mutant with a
deletion of the first four amino acids had a very low
fusion activity (20%) compared to that of the wt F protein
while showing wt levels of F cell surface expression.
These results suggested that the first four residues in
this region may have a critical role in the fusion process.
This result then raised the question whether only the
first four amino acids are required in this region for F
fusion activity. A deletion mutant, 478del8, retaining the
first four amino acids (aa 474–477) and lacking the last
eight amino acids (aa 478–485) in this region, was there-
fore generated. This mutant exhibited only about 40%
b-gal activity of the wt F protein but showed wt levels of
PI2 F cell surface expression, suggesting that spacing in
this region also played a role. This finding is consistent
with results that spacing in the region immediately ad-
jacent to the TM domain is critical for the fusogenic
activity of the simian virus 5 F protein (Zhou et al., 1997).
uantitation of the b-gal activities for two insertion mu-
ants, 47814 and 48614, indicated 5% of wt b-gal activ-
ity, also demonstrating an important role of spacing in
this region.
To further investigate the role of individual amino ac-
ids, we determined the effects of individual amino acid
substitutions with alanine or other indicated amino acid
TABLE 1
FACS Analysis of Cell Surface Expression
of wt and Mutant PI2 F Proteins
F construct
Fluorescence
intensitya F construct
Fluorescence
intensitya
wt PI2 F 1.00 474del4 1.16
S474A 1.01 478del4 0.67
N475A 1.01 482del4 0.97
F476A 0.84 478del8 1.27
F477A 0.98 47814 0.88
A478N 0.73 48614 0.78
N479A 1.12 N475Q 0.87
Q480A 0.94 N475D 0.89
A481R 0.98 F476W 1.13
R482A 0.94 F476H 0.76
T483A 0.89 F476Y 1.13
A484K 1.07 F476I 1.24
K485A 1.13 F477W 1.05
474del12 0.98 F477H 0.73
474-PI3 0.98 F477Y 1.12
a Fluorescence intensity is determined from mean fluorescence in-
ensity in FACS analysis. The fluorescence intensity of wt PI2 F is
ormalized as 1 and the fluorescence intensity of F mutants is normal-
zed to wt PI2 F.residues. As shown in Fig. 3B, S474A had no effects on
b
PHPIV2 F/HN-induced cell fusion. However, a complete
inhibition of HPIV2 F/HN-induced cell fusion activity was
observed when amino acids 475, 476, and 477 were
singly substituted with alanine (N475A, F476A, and
F477A), which also correlated with the results that dele-
tions (474del12 or 474del4) that removed these amino
acids would significantly inhibit F-induced cell fusion.
The N475A, F477A, 474del12, and 474del4 mutants all
had similar levels of cell surface expression to wt F; only
F476A showed a decreased cell surface expression.
Both A478N and N479A exhibited about 50–60% wt b-gal
activity, while only A478N showed a reduced level of F
cell surface expression. Q480A, A481R, and T483A all
had about 100% of the b-gal activity measured for the
ild-type HPIV2 F protein. R482A, A484K, and K485A
xhibited about 60% wt b-gal activity. These partially
educed fusion activities could be the result of introduc-
ion of charged residue A484K and polar residue A478N,
r replacement of charged residues R482A and K485A
nd polar residue N479A, which may change the F pro-
ein structure slightly.
The three amino acids in this region which appeared
o be most critical for fusion activity are uncharged polar
esidue asparagine (N) at the 475 position and two con-
ecutive nonpolar residues, phenylalanines (F) at the 476
FIG. 2. Oligomerization of wild-type and mutant HPIV2 F proteins.
HeLa T4 cells expressing wt and mutant F proteins were labeled with
[35S]Met/Cys using a pulse-chase protocol as described under Mate-
ials and Methods. Cell lysates extracted using the detergent 0.5%
onidet P-40 were treated with DTSSP. F molecules were then isolated
y immunoprecipitation and were analyzed by nonreducing 3.5% SDS–
AGE. The three predominant species (1, 2, and 3) are indicated.
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56 TONG ET AL.and 477 positions. To further examine the specific re-
quirements for the individual residues in this region, we
mutated asparagine into glutamine, which has a similar
uncharged polar chain (N475Q), and into aspartic acid,
which has a charged polar side chain (N475D). Similarly,
we mutated both nonpolar phenylalanine residues into
tryptophan, F476W, F477W; tyrosine, F476Y, F477Y; or
histidine, F476H, F477H, respectively. These F proteins
were analyzed for their fusogenicity by coexpression
with wt HPIV2 HN in HeLa T4 cells. As shown in Fig. 3C,
the N475D mutant had near-background levels of fusion
but the N475Q mutant showed b-gal activity, which was
equivalent to that observed for the wt F protein, whereas
both N475D and N475Q mutants had reduced cell sur-
face expression. Mutation of the phenylalanine at the 476
position into tyrosine or tryptophan, or mutation of the
phenylalanine at the 477 position into a tyrosine residue
resulted in fusion phenotypes similar to that of the wt F
protein. Mutants with histidine substitutions at either the
F476 or F477 position, although showing lower levels of
cell surface expression, still had similar levels of the
fusion activity measured for the wt F protein. Mutants
with tryptophan substitution at the F477 residue or iso-
leucine substitution at the F476 residue, which both had
similar levels of surface expression to wt PI2 F cell,
completely lacked F protein fusion activity. These results
indicate that the moiety itself is not specifically required
at these positions, but the structure and/or the size of the
residue that occupies the position are important for fu-
sion activity. Histidine substitution at either F476 or F477
resulted in slightly reduced fusion activity and lower
levels of cell surface expression.
Inhibition of cell fusion by synthetic peptides
It was previously shown that a peptide designated
2F1B34, corresponding to HRB plus the region between
HRB and the transmembrane domain of the HPIV2 F
protein, has the potential to inhibit HPIV2 virus-induced
cell fusion (Yao and Compans, 1996). To further investi-
gate the importance of the N475, F476, and F477 resi-
dues in this region for the fusion process, we synthe-
sized two peptides: one peptide (2F1B34D4) had the
same amino acid composition as 2F1B34 but a deletion
of the first four amino acids (S474, N475, F476, and F477),
and the other peptide (2F1B34T8) had a sequence cor-
responding to HRB elongated by only four amino acids
(S474, N475, F476, and F477). We compared the cell
fusion inhibition ability of these two peptides to that of
the peptide 2F1B34 by adding the peptides to HPIV2
F/HN-expressed cell cultures. At 16 h posttransfection,
inhibition of HPIV2 F/HN-induced cell fusion was exam-
ined. As shown in Table 2, without addition of peptide,
extensive cell fusion induced by HPIV2 F/HN was ob-
served. Addition of 2F1B34 peptide at a concentration ofFIG. 3. Quantitative colorimetric assay of cell fusion activity. One
opulation of HeLa-T4 cells was infected with recombinant vaccinia
TF7-3 and transfected with the wt HPIV2 HN and a series of F mutants
hown in (A), (B), and (C). Each of the F mutants is labeled below each
olumn or otherwise indicated and then treated with neuraminidase to
revent cell fusion before the two cell types were mixed. Cytosine
rabinoside (40 mg/ml) was added to each plate. A second population
of HeLa-T4 cells was infected with vaccinia IHD-J and transfected with
plasmid pGINT7 b-gal, which contains the b-galactosidase gene under
control of the T7 promoter. After 16 h posttransfection at 32°C, the two
populations of cells were trypsinized and mixed by adding 100 ml of
ach cell population (106 cells/ml) in a 96-well tissue culture plate. The
plate was incubated at 37°C for 5 h and cell fusion was measured by
the colorimetric lysate assay. The data are presented as percentage of
the b-galactosidase production observed in the cells transfected with20 mM was found to completely inhibit cell fusion in-
“
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57PARAINFLUENZA VIRUS F PROTEINduced by coexpression of HPIV2 F/HN. However, after
addition of either one of the two mutant peptides at a
concentration of 20 mM, 20–30% of wild-type levels of cell
fusion induced by coexpression of HPIV2 F/HN was still
observed, indicating an inefficient inhibitory effect.
These results show that the peptide which retained all 12
membrane-proximal amino acids has the most potent
antiviral activity.
Mutation of membrane-proximal amino acids inhibits
hemifusion
A GPI-anchored HPIV2 F, when coexpressed with wt
HPIV2 HN, was previously shown to promote hemifusion
but not complete fusion (Tong and Compans, 2000). To
examine whether the HPIV2 F mutants altered at the
membrane-proximal region which could not induce com-
plete fusion were still able to initiate hemifusion, we
employed the octadecyl rhodamine B (R18) assay (Bagai
and Lamb, 1995). The lipophilic probe R18 was incorpo-
rated into guinea pig RBCs, which then were mixed with
cells that coexpressed various HPIV2 F mutants with wt
HPIV2 HN protein. After cells were bound with R18-
labeled RBCs at 4°C for 1 h, the cells were then incu-
bated at 37°C for 1 h. As shown in Fig. 4, in cells
coexpressing the wt HPIV2 F with homotypic wt HPIV2
HN, transfer of fluorescence from the RBCs to the ex-
pressing cells was observed. However, in cells coex-
pressing any of the fusion-defective F mutants such as
N475A, F476A, F477A, 474del12, 47814, or 474-PI3, with
wt HPIV2 HN, no transfer of fluorescence from R18-
labeled RBCs to the expressing cells was observed.
These results indicated that the loss of fusogenicity of
the F mutants is the result of their inability to initiate the
outer leaflet membrane mixing step in the cell fusion
process.
DISCUSSION
Membrane fusion involves rearrangements and a lo-
calized disruption of the constituent lipid molecules in
TABLE 2
Inhibition of Cell Fusion by F Peptides
Plasmids Control 2F1B34 2F1B34D4 2F1B34T8
HPIV2 F/HN 1111a 2 11 11
Note. HeLa T4 cells were infected with vTF7-3 at a m.o.i. of 10 at
37°C for 1 h and then were transfected with wt HPIV2 F/HN genes. At
6 h posttransfection, F peptides were added to the culture media. At 16
h posttransfection, syncytia formation was examined in four different
zones and inhibition of cell fusion was determined.
a “1111” indicates that over 60% of nuclei are present in syncytia;
11” indicates that about 20% of nuclei are present in syncytia; “2”
ndicates that no syncytia are seen.the two membranes. The role of the fusion protein mightbe involved in overcoming inherent energy barriers and
catalyzing the formation of a fusion pore structure be-
tween the apposing membranes, allowing for the mixing
of aqueous contents (Siegel, 1993; Blumenthal and Di-
mitrov, 1997). Although the molecular structure of the
fusion pore has not been elucidated for any of the inter-
mediate steps, important functional and structural prop-
erties of fusion protein are emerging. Similarities in
structure among widely disparate viral fusion proteins
suggested that a common mechanism is involved in
membrane fusion (Hernandez et al., 1996; Durell et al.,
1997; Joshi et al., 1998; Baker et al., 1999; Weissenhorn et
al., 1999; Matthews et al., 2000). According to recent
virus-membrane fusion models it is believed that a con-
formational change in fusion proteins during the activa-
FIG. 4. Hemifusion of R18-labeled RBCs with HeLa-T4 cells coex-
pressing HPIV2 HN and wt HPIV2 F or mutant HPIV2 F proteins that did
not induce cell fusion. The lipophilic probe R18 was incorporated into
guinea pig RBCs which then were mixed with cells that coexpressed wt
HPIV2 HN with F proteins indicated as (A) wt PI2 F, (B) N475A, (C)
F476A, (D) F477A, (E) 474del12, (F) 47814, (G) 474-PI3, and (H) vector
pGEM3. After cells were bound with R18-labeled RBCs at 4°C for 1 h,
the cells were then incubated at 37°C. After a 1 h incubation, R18
transfer from RBCs to cells was visualized and photographed with a
Nikon fluorescence microscope using a “rhodamine” filter set.
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58 TONG ET AL.tion process results in extension of the coiled-coil struc-
ture and exposure of the hydrophobic “fusion peptide”
domain, which inserts into the target cell membrane and
locally destabilizes the lipid bilayer. Interaction between
the HRA domain adjacent to the fusion peptide and the
HRB domain adjacent to the transmembrane anchor in-
duces formation of a hairpin structure by the bending in
half of the fusion protein at a central hinge region, and
thus positions the transmembrane anchor and the fusion
peptide next to each other, concomitantly pulling the two
membranes into close proximity and potentially allowing
for formation of the fusion pore (Joshi et al., 1998; Weis-
senhorn et al., 1998; Baker et al., 1999; Dutch et al., 1999;
Matthews et al., 2000). This model indicates that fusion
equires precise conformational changes so that the
undamental structural elements of fusion proteins such
s the fusion peptide and heptad repeats are properly
ositioned to initiate fusion pore formation.
To investigate the role of the 12-residue membrane-
roximal region of the HPIV2 F protein, we screened this
egion by PCR-directed mutagenesis to construct a se-
ies of HPIV2 F mutants. These altered F proteins were
haracterized for their expression at the cell surface,
iological activities, and oligomer formation compared
ith that of the wt HPIV2 F protein. We initially found that
he amino acids in this region are not dispensable and
re also sequence specific for F protein fusion activity,
ecause F mutants with deletion or replacement of all 12
mino acids completely lost the ability to induce syncy-
ium formation. This suggests that at least part of the
inker sequence in the PI2 F protein is important for its
usogenic activity. The crystal structure of the core trimer
rom the SV5 F protein shows a trimer of antiparallel
oiled-coil heterodimers, which are formed by two dis-
ontinuous HRA and HRB motifs. A conformational
hange is thought to be important for formation of the
usogenic structure of the F protein, and the membrane-
roximal region might be a flexible tether that is required
or a fusogenic conformational change and for the proper
ositioning of the fusion protein molecules between the
wo fused lipid bilayers. Deletion of eight or more resi-
ues, insertion of four residues, or substitution of certain
esidues in this region might result in altered flexibility,
hich in turn could modify the position of the fundamen-
al structural elements such as HRB, leading to unsuc-
essful fusion. In addition, the observed inability of mu-
ated HPIV2 F proteins to initiate hemifusion indicated
hat these membrane-proximal residues are required in
nitiating lipid mixing. This result is consistent with the
inding that an HRB-derived peptide is a potent inhibitor
f the lipid mixing activity of the SV5 F protein (Lamb et
l., 1999).
It was previously observed that deletion of the mem-
rane-proximal 17-residue region in the HIV gp41 protein
r 39 residues in the MMLV Env-TM protein also had a
ignificant negative effect on their induction of mem-rane fusion (Fass et al., 1996; Salzwedel et al., 1999).
owever, the linker region between the coiled-coil trimer
nd the TM anchor from the SV5 F protein can be deleted
ithout preventing F-mediated fusion (Zhou et al., 1997;
aker et al., 1999). The linker residues between HRB and
he transmembrane domain are highly variable among
aramyxoviral fusion proteins in sequence and in the
umbers of amino acids, such as five residues in mumps
irus, seven residues in SV5, 12 residues in HPIV2, and
1 residues in HPIV3, indicating that this sequence might
lay a specific role in fusogenic activity of fusion pro-
eins. It is also possible that these residues interact with
corresponding linker region between the fusion pep-
ide and HRA during formation of the fusogenic confor-
ation.
The following evidence suggests that the N475, F476,
nd F477 residues of HPIV2 F play a critical role in fusion
ctivity. First, deletion of groups of four of the last eight
mino acids had minimal effects on HPIV2 F/HN-induced
ell fusion, while deletion of the first four amino acids,
hich included N, F, and F, prevented HPIV2 F/HN-in-
uced cell fusion. Second, single substitution of any of
hese three amino acids by alanine completely blocked
he F protein fusion activity; in contrast, single substitu-
ion of other residues by alanine or other amino acids
ad little or no effect on HPIV2 F/HN-induced cell fusion.
hird, a synthetic peptide with deletion of S474, N475,
476, and F477 residues showed incomplete inhibition of
PIV2 F/HN-induced cell fusion compared to that of the
eptide (2F1B34) including these four residues. Since
ocrystallized HRA- and HRB-derived peptides from the
V5 F protein were reported to form a very stable six-
elical bundle (Joshi et al., 1998; Dutch et al., 1999), a
likely mechanism for the peptide-inhibitory effect in-
volves an interaction of the peptide with the heptad
repeats, affecting a conformational change in the F pro-
tein which may be required for fusion. This possibility is
supported by the finding that in the Newcastle Disease
virus F protein, individual peptides derived from HRA or
HRB each inhibited fusion, whereas mixtures of the two
peptides had a minimal effect on fusion, suggesting that
two peptides form a complex that prevents their interac-
tion with the target protein (Young et al., 1999).
The observations that the all mutated F proteins are
present at the cell surface and are found in the same
oligomeric state, as is the wt F protein, indicate that the
differences in syncytium-forming ability of the wild-type
and mutant HPIV2 F proteins are not the result of defects
in transport or assembly. Some F mutants which had
less-efficient cell surface expression retained the same
level of fusion activity as that of wild-type PI2 F protein
(T483A, F476H, F477H and 478del4, N475Q), indicating
that these levels of cell surface expression of F proteins
are sufficient to induce syncytium formation. Thus it is
unlikely that reduction of F protein levels on cell surfaces
could account for the complete absence of fusion activity
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pression levels of fusion proteins could affect their fuso-
genic activity to a certain degree.
Taken together, the results of this study suggest that
the membrane-proximal amino acids of the HPIV2 F
protein are not dispensable and that three amino acids
(N475, F476, and F477) in this region play a critical role
for fusogenic activity of the HPIV2 F protein. None of the
12 membrane-proximal amino acids is necessary for
oligomer formation or cell surface expression. They are
most likely to be involved in the process of initiating lipid
mixing by mediating or supporting the correct conforma-
tional change required for fusion activity. The biological
relevance of this region is also consistent with its loca-
tion adjacent to HRB and the transmembrane anchor,
both of which are known to play important roles in mem-
brane fusion.
MATERIALS AND METHODS
Cells, viruses, and plasmids
HeLa T4 cells were maintained in Dulbecco’s modified
Eagle’s minimal essential medium (DMEM) supple-
mented with 10% fetal calf serum (HyClone Laboratories,
Logan, UT). The recombinant vaccinia virus vTF7-3 was
kindly provided by Bernard Moss (National Institutes of
Health, Bethesda, MD). All recombinant bacterial plas-
mids were propagated in an Escherichia coli DH5a strain
recA hsdR). The pGEM-3-PI2F, pGEM-3-PI2HN, pGEM-
-PI3F, and pGEM-3-PI3HN plasmids were described
reviously (Hu et al., 1992). Plasmid pG1NT7 b-gal was
kindly provided by Edward Berger (National Institutes of
Health). Rabbit anti-HPIV2 antibody was described pre-
viously (Hu et al., 1992).
Peptides
Peptide 2F1B34, which corresponds to a 34-mer seg-
ment (amino acids 452 to 485) of the HPIV2 F protein,
was described previously (Yao and Compans, 1996). Pep-
tide 2F1B34D4, which has a deletion of S474, N475, F476,
and F477 residues in peptide 2F1B34, and peptide
2F1B34T8, which has truncation of the last eight resi-
dues in peptide 2F1B34, were obtained from the Micro-
biology and Immunology Peptide Facility of Emory Uni-
versity and were characterized by mass spectrometry.
Construction of F mutant proteins
All HPIV2 F protein mutants except for 474del12 and
474-PI3 were constructed by PCR using a QuikChange
Site-Directed Mutagenesis Kit according to the manufac-
turer’s instruction manual (Stratagene, LaJolla, CA). The
pGEM3-PI2F plasmid was used as the template and two
synthetic oligonucleotide primers (from Fisher Scientific-
Genosys, Springfield, NJ) containing the desired muta-
tion were complementary to each other. During PCR theoligonucleotide primers were extended by means of PFU
DNA polymerase. The resulting PCR product was a mu-
tated plasmid containing staggered nicks, which was
then treated with DpnI to digest the parental DNA tem-
plate. The nicked plasmid DNA incorporating the desired
mutations was then transformed into E. coli and was
selected on LB plates with antibiotics.
The 474del12 and 474-PI3 protein mutants were con-
structed by the overlapping PCR technique described by
Ho et al. (1989) and Horton et al. (1989). The ectodomain
equence with a deletion of C-terminal 12 residues and
ransmembrane domain/cytoplasmic tail sequence were
CR-amplified separately from the HPIV2 F clone. The
ntisense primer for the HPIV2 F ectodomain fragment
ontained either a 12- or a 36-nucleotide overhang at the
9-end complementary to the 59-end of the sense primer
or transmembrane/cytoplasmic domain sequence. The
equence for the region between HRB and the trans-
embrane domain from HPIV3 F was encoded in de-
igned primers which have a 36-nucleotide overhang.
he two amplified PCR sequences were annealed to
ach other and were further extended to generate the
himeric genes by five cycles of PCR. Finally, the chi-
eric 474-PI3 F gene or HPIV2 F gene with a 12-residue
eletion was used as template and amplified by PCR
sing two outer primers. The resulting chimeras flanked
ith SalI/EcoRI sites were cloned into vector pGEM-3 at
he SalI/EcoRI sites. All end products were sequenced to
onfirm that the correct sequence had been obtained in
he PCRs. A schematic diagram of the constructs is
hown in Fig. 1.
xpression of F mutant proteins
The mutant and wild-type HPIV2 F proteins were ex-
ressed by using the vaccinia virus-bacteriophage T7
NA polymerase transient expression system (Fuerst et
l., 1986). In brief, 35-mm dishes of subconfluent cells
ere infected for 1 h with vTF7-3 at an m.o.i. of 10 and
hen transfected with 5 mg of plasmid DNA mixed with 10
ml of Lipofectin (GIBCO-BRL, Gaithersburg, MD) in 1 ml of
DMEM. At 16 h posttransfection, the transfected cells
were starved in DMEM lacking methionine and cysteine
for 30 min, pulse-labeled with 100 mCi/ml of [35S]methi-
onine/cysteine for 30 min at 37°C, and then chased with
nonradioactive chase medium (DMEM containing 10%
fetal calf serum) for 2 h. The cells were washed and then
lysed with cell dissociation buffer (10 mM Tris–HCl, pH
8.0; 250 mM NaCl; 0.5% Triton X-100; and 0.5% sodium
deoxycholate). The cell lysate was analyzed for F protein
expression by incubation with HPIV2-hyperimmune rab-
bit serum for $2 h at 4°C followed by precipitation with
protein A–agarose (Immunopure; Pierce Chemical, Rock-
ford, IL) for 2 h. Proteins were characterized by sodium
dodecyl sulfate–8% polyacrylamide gel electrophoresis
(SDS–8% PAGE) and by subsequent autoradiography.
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60 TONG ET AL.Flow-cytometric analysis
Indirect immunofluorescent staining was done in
HeLa T4 cells, which were grown to 50–85% confluency
nd transfected with the different indicated constructs by
sing Lipofectin according to the manufacturer’s recom-
endations (GIBCO BRL). Sixteen hours after transfec-
ion, the cells were detached from culture dishes using 5
M EDTA, transferred to microcentrifuge tubes, fixed in
% paraformaldehyde for 30 min on ice, and then washed
wice in PBS buffer. The fixed cells were first reacted on
ce with polyclonal rabbit antibodies against PI2 for 30
in on ice and then stained with fluorescein isothiocya-
ide (FITC)-conjugated goat anti-rabbit immunoglobulin
. The fluorescence intensity of 10,000 cells was mea-
ured by a FACSCAN flow cytometer (Becton Dickinson,
ountain View, CA).
hemical cross-linking
Chemical cross-linking of proteins in Nonidet P-40
NP-40)-solubilized cell lysates was performed as de-
cribed by Russell et al. (1994) using the cross-linking
eagent 3,39-dithiobis (sulfosuccinimidyl propionate)
DTSSP; Pierce Chemical). Briefly, subconfluent monolay-
rs of HeLa-T4 cells in 35-mm dishes were transfected
nd metabolically labeled by a protocol similar to that
escribed above. The radiolabeled cells were detached
rom the dish with 5 mM EDTA in PBS, washed, and
esuspended in 100 ml of PBS deficient in Mg21 and Ca21
(PBS2). The cells were solubilized in 0.5% NP-40, treated
with 2 mM DTSSP at 4°C for 60 min, and inactivated with
50 mM glycine for 5 min a 4°C. Immunoprecipitations
were performed as described above and the precipitates
were analyzed by SDS–3.5% PAGE under nonreducing
conditions.
Cell fusion assays
Dishes (35 mm) of 80% subconfluent HeLa T4 cells
were infected for 1 h with vTF7-3 at an m.o.i. of 10 and
then cotransfected with 2.5 mg of altered mutant or wt
HPIV2 F plasmid DNA and 2.5 mg of wt HPIV2 HN
plasmid DNA mixed with 10 ml of Lipofectin (GIBCO-BRL)
n 1 ml of DMEM. After 16 h of incubation at 37°C, the
ormation of syncytia was compared with cells cotrans-
ected with wt HPIV2 F/HN. For assays of peptide inhi-
ition of cell fusion, after incubation for 6 h at 37°C, the
noculum was removed and DMEM with addition of dif-
erent peptides at a concentration of 20 mM was added.
After a 16-h incubation at 37°C, the formation of syncytia
was compared with addition of peptide 2F1B34 or no
peptide. Cell fusion was measured by polykaryon forma-
tion and expressed as (number of nuclei in polykaryons/
number of total nuclei) 3 100. Cells were counted in four
ifferent fields under a light microscope.
A quantitative cell fusion assay was performed ac-ording to the fusion-dependent reporter gene activation
ethod described by Nussbaum et al. (1994) with slight
odifications. One population of HeLa-T4 cells was in-
ected with recombinant vaccinia vTF7-3 and transfected
ith the wt HPIV2 HN and a series of F mutants and then
reated with neuraminidase to prevent cell fusion before
he two cell types were mixed. Cytosine arabinoside (40
mg/ml) was added to each plate. A second population of
HeLa-T4 cells was infected with vaccinia IHD-J and
transfected with plasmid pGINT7 b-gal, which contains
he b-galactosidase gene under control of the T7 pro-
oter. Sixteen hours posttransfection, the two popula-
ions of cells were collected and mixed by adding 100 ml
of each cell population (106 cells/ml) in a 96-well tissue
culture plate. The plate was incubated at 37°C for 5 h
and cell fusion was measured by the colorimetric lysate
assay as described previously (Yao and Compans, 1995).
Fusion activity was expressed as a percentage of the
amount of b-galactosidase production in the cells trans-
ected with wt HPIV2 F/HN plasmids.
emifusion assay
Guinea pig erythrocytes (RBCs) were labeled with the
ydrophobic fluorescent dye R18 (Molecular Probes, Eu-
ene, OR) based on the procedure described by Bagai
nd Lamb (1995). In brief, 15 ml of 1 mg/ml R18 in ethanol
was added to 10 ml of 1% fresh guinea pig erythrocyte
suspension in PBS while vortexing. After incubation at
room temperature in the dark for 30 min, 30 ml of DMEM
with 10% fetal calf serum was added to the suspension
and further incubated for 20 min to absorb the unbound
probe. After labeling, the RBC suspension was washed
five times with 40 ml of PBS to remove the unincorpo-
rated R18. The last washing step was in PBS containing
additional 1 mM CaCl2 and 1 mM MgCl2 (PBS11). To
determine hemifusion, HeLa T4 cell monolayers ex-
pressing HPIV2 F/HN or expressing F mutants and wt
HPIV2 HN at 16 h posttransfection at 32°C were washed
twice with DMEM and then incubated for 1 h at 37°C
with 50 mU per ml of neuraminidase in DMEM. The
neuraminidase-treated cells were washed twice with
PBS and first incubated with 1 ml of R18-labeled RBCs
(0.2% hematocrit) in PBS11 at 4°C for 1 h in the dark
with intermittent gentle agitation and then incubated at
37°C for 1 h. Unbound RBCs were removed by two
washes with PBS. Fusion was monitored and photo-
graphed by using an inverted fluorescence microscope.
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